Center for Scientific Review Amended; Notice of Meeting, 55497-55498 [2014-21950]
Download as PDF
<![CDATA[
55497
Federal Register / Vol. 79, No. 179 / Tuesday, September 16, 2014 / Notices
interest. Three project areas that
initially participated in MMP—and
were subsequently dropped in 2009
because funding was restricted—will be
reinstated as primary sampling units if
funding allows.
Increasing the sample size in three
areas that were previously allocated
comparatively small samples (Georgia,
Illinois, and Pennsylvania) is expected
to improve the ability to produce
representative local estimates in these
areas.
Health care facility staff may be asked
to look up contact information for
sampled persons with incomplete or
incorrect contact information in NHSS;
this was not necessary in prior MMP
cycles because the patient samples were
drawn from facility records.
Finally, changes were made that did
not affect the burden, listed below:
• The interview instrument was
revised to enable the collection of
critical information from HIV-infected
persons not receiving medical care and
to improve question coherence, boost
the efficiency of the data collection, and
increase the relevance and value of the
in the interview and facilitate
communication between respondent
and interviewer, for example, by
allowing interviewers to respond
appropriately to a respondent’s visual
cues. Videoconferencing will also allow
the interviewer to ensure that the
respondent is using the correct response
cards for interview questions. No audio/
audiovisual recordings will be made of
the interviews, including interviews
administered by videoconferencing.
This proposed data collection would
supplement the National HIV
Surveillance System (NHSS, OMB
Control No. 0920–0573, Exp. 2/29/2016)
in 26 selected state and local health
departments, which collect information
on persons diagnosed with, living with,
and dying from HIV infection and AIDS.
The participation of respondents is
voluntary. There is no cost to the
respondents other than their time.
Through their participation,
respondents will help to improve
programs to prevent HIV infection as
well as services for those who already
have HIV.
information. These changes were based
on an evaluation of the currently
approved MMP interview instrument
involving stakeholders, as well as a pilot
which evaluated new questions
(Formative Research and Tool
Development, OMB Control No. 0920–
0840, expiration 2/29/2016). These
revisions did not change the average
time required to complete the interview.
• Six data elements were removed
from the medical record abstraction
form and two data elements were added.
Because the medical records are
abstracted by MMP staff, these changes
do not affect the burden of the project
on the public.
• Sampled persons may be
interviewed wherever they currently
reside, conditional on local law and
policy, and in a manner specified by a
written, project-specific agreement with
the HIV surveillance unit at the person’s
local health department.
• Videoconferencing was added as an
optional mode of interview
administration. Administering the
interview via videoconferencing will
provide more flexibility for participating
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average hours
per response
(in hours)
8,720
2,180
1
1
45/60
2/60
6,540
73
...............................................
1,090
1
5/60
91
...............................................
8,720
1
3/60
436
...............................................
........................
........................
........................
7,140
Number of
respondents
Type of respondent
Form name
Sampled, Eligible HIV-Infected Persons ......
Facility office staff looking up contact information.
Facility office staff approaching sampled
persons for enrollment.
Facility office staff pulling medical records ...
Interview Questionnaire ........
...............................................
Total .......................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–22010 Filed 9–15–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
FOR FURTHER INFORMATION CONTACT:
tkelley on DSK3SPTVN1PROD with NOTICES
[Docket No. FDA–2014–D–1288]
Draft Guidance for Industry: Electronic
Submission of Lot Distribution
Reports; Availability; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
18:22 Sep 15, 2014
Lori
J. Churchyard, Center for Biologics
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 7301,
Silver Spring, MD 20993–0002, 240–
402–7911.
In the
Federal Register of Friday, August 29,
SUPPLEMENTARY INFORMATION:
Notice; correction.
VerDate Sep<11>2014
The Food and Drug
Administration is correcting a notice
entitled ‘‘Draft Guidance for Industry:
Electronic Submission of Lot
Distribution Reports; Availability’’ that
appeared in the Federal Register of
August 29, 2014 (79 FR 51576). The
document announced the availability of
a draft guidance entitled ‘‘Guidance for
Industry: Electronic Submission of Lot
Distribution Reports’’ dated August
2014. The document was published
with the incorrect docket number. This
document corrects that error.
SUMMARY:
Jkt 232001
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Total
burden
hours
2014, in FR Doc. 2014–20635, on page
51576, the following correction is made:
1. On page 51576, in the first column,
in the Docket No. heading, ‘‘[FDA–
2014–S–0009]’’ is corrected to read
‘‘[FDA–2014–D–1288]’’.
Dated: September 10, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–22015 Filed 9–15–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Amended;
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Neurotransporters,
Receptors, and Calcium Signaling Study
E:\FR\FM\16SEN1.SGM
16SEN1
55498
Federal Register / Vol. 79, No. 179 / Tuesday, September 16, 2014 / Notices
Section, October 2, 2014, 8:00 a.m. to
October 3, 2014, 12:00 p.m., Hotel
Monaco, 700 F Street NW., Washington,
DC 20001 which was published in the
Federal Register on September 4, 2014,
79 FR 52738.
The meeting will be held on October
2, 2014, 8:00 a.m. to 9:00 p.m. The
meeting location remains the same. The
meeting is closed to the public.
Dated: September 10, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–21950 Filed 9–15–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group
Dissemination and Implementation Research
in Health Study Section.
Date: October 14–15, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Martha L. Hare, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3154,
Bethesda, MD 20892, (301) 451–8504,
harem@mail.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group
Tumor Cell Biology Study Section.
Date: October 15–16, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Row Hotel, 2015
Massachusetts Avenue NW., Washington, DC
20036.
Contact Person: Charles Morrow, MD,
Ph.D., Scientific Review Officer, Center for
VerDate Sep<11>2014
18:22 Sep 15, 2014
Jkt 232001
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, 301–451–
4467, morrowcs@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group Somatosensory and
Chemosensory Systems Study Section.
Date: October 15–16, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Silver Spring Hotel, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: M. Catherine Bennett,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7846, Bethesda, MD 20892, 301–435–
1766, bennettc3@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cancer,
Cardiovascular and Sleep Epidemiology
Panel B.
Date: October 15–16, 2014.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Julia Krushkal, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, 301–435–
1782, krushkalj@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group
Oral, Dental and Craniofacial Sciences Study
Section.
Date: October 15–16, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Wardman Park Washington
DC Hotel, 2660 Woodley Road NW.,
Washington, DC 20008.
Contact Person: Yi-Hsin Liu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892, 301–435–
1781, liuyh@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group
Clinical Research and Field Studies of
Infectious Diseases Study Section.
Date: October 15–16, 2014.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Soheyla Saadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3211,
MSC 7808, Bethesda, MD 20892, 301–435–
0903, saadisoh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Basic and Integrative
Bioengineering.
Date: October 15, 2014.
Time: 8:30 a.m. to 5:00 p.m.
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Paul Sammak, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6185,
MSC 7892, Bethesda, MD 20892, 301–435–
0601, sammakpj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Hypertension and Microcirculation.
Date: October 15, 2014.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Katherine M Malinda,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, 301–435–
0912, Katherine_Malinda@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Research Project Grant.
Date: October 15, 2014.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Melinda Jenkins, FNP,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3156,
MSC 7770, Bethesda, MD 20892, 301–437–
7872, jenkinsml2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 10, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–21953 Filed 9–15–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
E:\FR\FM\16SEN1.SGM
16SEN1
]]>Agencies
[Federal Register Volume 79, Number 179 (Tuesday, September 16, 2014)]
[Notices]
[Pages 55497-55498]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21950]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Amended; Notice of Meeting
Notice is hereby given of a change in the meeting of the
Neurotransporters, Receptors, and Calcium Signaling Study
[[Page 55498]]
Section, October 2, 2014, 8:00 a.m. to October 3, 2014, 12:00 p.m.,
Hotel Monaco, 700 F Street NW., Washington, DC 20001 which was
published in the Federal Register on September 4, 2014, 79 FR 52738.
The meeting will be held on October 2, 2014, 8:00 a.m. to 9:00 p.m.
The meeting location remains the same. The meeting is closed to the
public.
Dated: September 10, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-21950 Filed 9-15-14; 8:45 am]
BILLING CODE 4140-01-P
